메뉴 건너뛰기




Volumn 83, Issue 4, 2011, Pages 71-77

Renin-angiotensin-aldosteron system: Evolution of views from renin discovery to nowadays. perspectives of therapeutic block

Author keywords

ACE 2; Aldosteron; Angiotensin ii; Direct renin inhibitor; Mas receptors; Prorenin; RAAS block; Renin

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN;

EID: 79959723788     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (36)
  • 2
    • 70449268977 scopus 로고
    • The location of renin in the rabbit kidney
    • Cook W. F., Pickering G. W. The location of renin in the rabbit kidney. J. Physiol. (Lond.). 1959; 149: 526-536.
    • (1959) J. Physiol. (Lond.). , vol.149 , pp. 526-536
    • Cook, W.F.1    Pickering, G.W.2
  • 3
    • 0025598309 scopus 로고
    • Identification of a high specific chymase as a major angiotensin II-forming enzyme in the human heart
    • Urata H., Kinoshita A., Misono K. S. et al. Identification of a high specific chymase as a major angiotensin II-forming enzyme in the human heart. J. Biol. Chem. 1990; 265: 22348-22357.
    • (1990) J. Biol. Chem. , vol.265 , pp. 22348-22357
    • Urata, H.1    Kinoshita, A.2    Misono, K.S.3
  • 4
    • 0023551807 scopus 로고
    • Different distribution of two types of angiotensin II-generating enzymes in the aortic wall
    • Okunishl H., Miyazaki M., Okamura T. et al. Different distribution of two types of angiotensin II-generating enzymes in the aortic wall. Biochem. Biophys. Res. Commun. 1987; 149: 1186-1192.
    • (1987) Biochem. Biophys. Res. Commun. , vol.149 , pp. 1186-1192
    • Okunishl, H.1    Miyazaki, M.2    Okamura, T.3
  • 5
    • 0027166170 scopus 로고
    • Angiotensin II receptor subtypes: Characterization, signaling mechanisms, and possible physiologic implications
    • Bottary S. P., de Gasparo M., Steckeling U. M. et al. Angiotensin II receptor subtypes: characterization, signaling mechanisms, and possible physiologic implications. Front. Neuroendocrinol. 1993; 14: 123-171.
    • (1993) Front. Neuroendocrinol. , vol.14 , pp. 123-171
    • Bottary, S.P.1    De Gasparo, M.2    Steckeling, U.M.3
  • 6
    • 0035347330 scopus 로고    scopus 로고
    • Angiotensin III: A central regulator of vasopressin release and blood pressure
    • Reaux A., Foumie-Zaluski M. C, Llorens-Cortes C. Angiotensin III: a central regulator of vasopressin release and blood pressure. Trends Endocrinol. Metab. 2001; 12: 157-162.
    • (2001) Trends Endocrinol. Metab. , vol.12 , pp. 157-162
    • Reaux, A.1    Foumie-Zaluski, M.C.2    Llorens-Cortes, C.3
  • 8
    • 0034721906 scopus 로고    scopus 로고
    • A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase
    • Tipnis S. R., Hooper N. M., Hyde R. et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 2000; 275: 3338-3343.
    • (2000) J. Biol. Chem. , vol.275 , pp. 3338-3343
    • Tipnis, S.R.1    Hooper, N.M.2    Hyde, R.3
  • 10
    • 0036266596 scopus 로고    scopus 로고
    • Pivotal role of the renin/prorenin receptors in angiotensin II production and cellular responses to renin
    • Nguyen G., Delante F., Burckle C. et al. Pivotal role of the renin/prorenin receptors in angiotensin II production and cellular responses to renin. J. Clin. Invest. 2002; 109: 1417-1427.
    • (2002) J. Clin. Invest. , vol.109 , pp. 1417-1427
    • Nguyen, G.1    Delante, F.2    Burckle, C.3
  • 11
    • 42649109044 scopus 로고    scopus 로고
    • Prorenin and (pro)renin receptor: A review of available data from in vitro studies and experimental models in rodents
    • Nguyen G., Danser A. H. Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents. Exp. Physiol. 2009; 93: 557-563.
    • (2009) Exp. Physiol. , vol.93 , pp. 557-563
    • Nguyen, G.1    Danser, A.H.2
  • 12
    • 0032787740 scopus 로고    scopus 로고
    • Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus
    • DOI 10.1007/s001250051260
    • Deinum J., Ronn B., Mathiesen E. et al. Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia 1999; 42: 1006-1010. (Pubitemid 29369610)
    • (1999) Diabetologia , vol.42 , Issue.8 , pp. 1006-1010
    • Deinum, J.1    Ronn, B.2    Mathiesen, E.3    Derkx, F.H.M.4    Hop, W.C.J.5    Schalekamp, M.A.D.H.6
  • 13
    • 0024495446 scopus 로고
    • Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy
    • Danser A. H., van den Dorpel M. A., Deinum J. et al. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J. Clin. Endocrinol. 1989; 68: 160-167.
    • (1989) J. Clin. Endocrinol. , vol.68 , pp. 160-167
    • Danser, A.H.1    Van Den Dorpel, M.A.2    Deinum, J.3
  • 14
    • 0007401947 scopus 로고
    • Stimulation of aldosterone secretion by angiotensin II
    • Mulrow P. J., Ganong W. F. Stimulation of aldosterone secretion by angiotensin II. Yale J. Biol. Med. 1961; 33: 386-395.
    • (1961) Yale J. Biol. Med. , vol.33 , pp. 386-395
    • Mulrow, P.J.1    Ganong, W.F.2
  • 15
    • 0027997406 scopus 로고
    • Vascular aldosterone. Biosynthesis and a link to angiotensin II induced hypertrophy of vascular smooth cells
    • Hatakeyama H., Miyamorl I., Fujita T. et al. Vascular aldosterone. Biosynthesis and a link to angiotensin II induced hypertrophy of vascular smooth cells. J. Biol. Chem. 1994; 269: 24316-24320.
    • (1994) J. Biol. Chem. , vol.269 , pp. 24316-24320
    • Hatakeyama, H.1    Miyamorl, I.2    Fujita, T.3
  • 16
    • 0029553195 scopus 로고
    • Aldosterone: Intracellular receptors in human heart
    • Bonvalet J. P., Alfaidy N., Farman N. et al. Aldosterone: intracellular receptors in human heart. Eur. Heart J. 1995; 16 (Suppl. N): 92-97.
    • (1995) Eur. Heart J. , vol.16 , Issue.SUPPL. N , pp. 92-97
    • Bonvalet, J.P.1    Alfaidy, N.2    Farman, N.3
  • 17
    • 0033625255 scopus 로고    scopus 로고
    • Expression of 11ß-hydroxylase and aldosterone synthase genes in the rat brain
    • MacKenzie S. M., Clark C. J., Fraser R. et al. Expression of 11ß-hydroxylase and aldosterone synthase genes in the rat brain. J. Mol. Endocrinol. 2000; 24: 321-328.
    • (2000) J. Mol. Endocrinol. , vol.24 , pp. 321-328
    • MacKenzie, S.M.1    Clark, C.J.2    Fraser, R.3
  • 18
    • 0036209144 scopus 로고    scopus 로고
    • Aldosterone sunthase (CYP 11B2) expression and myocardial fibrosis in the failing human heart
    • Satoh M., Nakamura M., Saitoh H. et al. Aldosterone sunthase (CYP 11B2) expression and myocardial fibrosis in the failing human heart. Clin. Sci. 2002; 102: 381-386.
    • (2002) Clin. Sci. , vol.102 , pp. 381-386
    • Satoh, M.1    Nakamura, M.2    Saitoh, H.3
  • 19
    • 0034657564 scopus 로고    scopus 로고
    • Impact of aldosterone on left-ventricular structure and function in young normotensive and mildly hypertensive subjects
    • Schlaich M. P., Schobel H. P., Hilgers K. et al. Impact of aldosterone on left-ventricular structure and function in young normotensive and mildly hypertensive subjects. Am. J. Cardiol. 2000; 85: 1199-1206.
    • (2000) Am. J. Cardiol. , vol.85 , pp. 1199-1206
    • Schlaich, M.P.1    Schobel, H.P.2    Hilgers, K.3
  • 21
    • 49649085000 scopus 로고    scopus 로고
    • The aggravating mechanisms of aldosterone on kidney fibrosis
    • Remuzzi G., Cattaneo D., Perico N. The aggravating mechanisms of aldosterone on kidney fibrosis. J. Am. Soc. Nephrol. 2008; 19: 1459-1462.
    • (2008) J. Am. Soc. Nephrol. , vol.19 , pp. 1459-1462
    • Remuzzi, G.1    Cattaneo, D.2    Perico, N.3
  • 22
    • 33748134355 scopus 로고    scopus 로고
    • Aldosterone, dietary salt, and renal disease
    • DOI 10.1161/01.HYP.0000230482.82239.a0, PII 0000426820060800000010
    • Pimenta E., Calhoun D. A. Aldosterone, dietary salt, and kidney disease. Hypertension 2006; 48: 209-210. (Pubitemid 44309812)
    • (2006) Hypertension , vol.48 , Issue.2 , pp. 209-210
    • Pimenta, E.1    Calhoun, D.A.2
  • 23
    • 4544313129 scopus 로고    scopus 로고
    • Non-genomic effects of aldosterone: New actions and questions
    • Tae-Yon Chun, Pratt J. H. Non-genomic effects of aldosterone: new actions and questions. Trends Endocrinol. Metab. 2004; 15: 353-354.
    • (2004) Trends Endocrinol. Metab. , vol.15 , pp. 353-354
    • Chun, T.-Y.1    Pratt, J.H.2
  • 24
    • 1342324062 scopus 로고    scopus 로고
    • Review of aldosterone- And angiotensin II-induced target organ damage and prevention
    • Struthers A. D., MacDonald T. M. Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovasc. Res. 2004; 61: 663-670.
    • (2004) Cardiovasc. Res. , vol.61 , pp. 663-670
    • Struthers, A.D.1    MacDonald, T.M.2
  • 25
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure
    • Pitt B., Zannad F., Remme W. J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 1999; 341: 709-717.
    • (1999) N. Engl. J. Med. , vol.341 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.J.3
  • 26
    • 0037417252 scopus 로고    scopus 로고
    • Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
    • Pitt B., Remme W., Zannad F. et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 2003; 348: 1309-1321.
    • (2003) N. Engl. J. Med. , vol.348 , pp. 1309-1321
    • Pitt, B.1    Remme, W.2    Zannad, F.3
  • 27
    • 0003131660 scopus 로고    scopus 로고
    • Efficacy and safety of eplerenon, enalapril, and eplerenon/enalapril combination therapy in patients with left ventricular hypertrophy
    • Pitt B., Reichek N., Metscher R. et al. Efficacy and safety of eplerenon, enalapril, and eplerenon/enalapril combination therapy in patients with left ventricular hypertrophy. Am. J. Hypertens. 2002; 15: 24A.
    • (2002) Am. J. Hypertens. , vol.15
    • Pitt, B.1    Reichek, N.2    Metscher, R.3
  • 28
    • 0001847493 scopus 로고    scopus 로고
    • Antiproteinuric efficacy of eplerenon, enalapril, and eplerenon/enalapril combination in diabetic hypertensives with microalbuminuria
    • Epstein M., Buckalew V., Martinez F. et al. Antiproteinuric efficacy of eplerenon, enalapril, and eplerenon/enalapril combination in diabetic hypertensives with microalbuminuria. Am. J. Hypertens. 2002; 15: 25A.
    • (2002) Am. J. Hypertens. , vol.15
    • Epstein, M.1    Buckalew, V.2    Martinez, F.3
  • 29
    • 0031475147 scopus 로고    scopus 로고
    • Role of local and systemic angiotensin in diabetic renal disease
    • Anderson S. Role of local and systemic angiotensin in diabetic renal disease. Kidney Int. 1997; 62 (Suppl. 63): 107-110.
    • (1997) Kidney Int. , vol.62 , Issue.SUPPL. 63 , pp. 107-110
    • Anderson, S.1
  • 30
    • 0033989542 scopus 로고    scopus 로고
    • Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure
    • Roig E., Perez-Villa F., Morales M. et al. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure. Eur. Heart J. 2000; 21: 53-57.
    • (2000) Eur. Heart J. , vol.21 , pp. 53-57
    • Roig, E.1    Perez-Villa, F.2    Morales, M.3
  • 31
    • 59949088729 scopus 로고    scopus 로고
    • Aliskiren: An oral renin inhibitor for the treatment of hypertension
    • Sanoski C. A., Pharm D. Aliskiren: an oral renin inhibitor for the treatment of hypertension. Pharmacotherapy 2009; 29: 193-212.
    • (2009) Pharmacotherapy , vol.29 , pp. 193-212
    • Sanoski, C.A.1    Pharm, D.2
  • 32
    • 44849114597 scopus 로고    scopus 로고
    • Aliskiren combined with losartan in type 2 diabetes and nephropathy
    • Parving H. H., Persson F., Lewis J. B. et al. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N. Engl. J. Med. 2008; 358: 2433-2446.
    • (2008) N. Engl. J. Med. , vol.358 , pp. 2433-2446
    • Parving, H.H.1    Persson, F.2    Lewis, J.B.3
  • 33
    • 77951499583 scopus 로고    scopus 로고
    • Prorenin, renin, and their receptor, moving targets
    • Reudelhuber T. L. Prorenin, renin, and their receptor, moving targets. Hypertension 2010; 55: 1071-1074.
    • (2010) Hypertension , vol.55 , pp. 1071-1074
    • Reudelhuber, T.L.1
  • 34
    • 77749298365 scopus 로고    scopus 로고
    • The past, present and future of AT2-receptor stimulation
    • Steckelings U. M., Rompe F., Kaschina E. et al. The past, present and future of AT2-receptor stimulation. JRAAS 2010; 11: 67-73.
    • (2010) JRAAS , vol.11 , pp. 67-73
    • Steckelings, U.M.1    Rompe, F.2    Kaschina, E.3
  • 35
    • 33847780798 scopus 로고    scopus 로고
    • Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonist
    • Santos R. A., Ferreira A. J. Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonist. Cardiovasc. Drug Rev. 2006; 24: 239-246.
    • (2006) Cardiovasc. Drug Rev. , vol.24 , pp. 239-246
    • Santos, R.A.1    Ferreira, A.J.2
  • 36
    • 64949189157 scopus 로고    scopus 로고
    • Aldosterone antagonism or synthase inhibition reduces end-organ damage induces by treatment with angiotensin and high salt
    • Lea W. B., Kwak E. S., Luther J. M. et al. Aldosterone antagonism or synthase inhibition reduces end-organ damage induces by treatment with angiotensin and high salt. Kidney Int. 2009; 75: 936-944.
    • (2009) Kidney Int. , vol.75 , pp. 936-944
    • Lea, W.B.1    Kwak, E.S.2    Luther, J.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.